| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |